Skip to main content

Graham Juan's Form 4/A amendment

Amended

Kyntra Bio, Inc. (KYNB) · filed Dec 15, 2022

Accession no.
0001209191-22-061485
Filed
Dec 15, 2022
Trade date
Dec 9-12, 2022
Filing delay
6 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Dec 14, 2022

This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $32.0K. It was filed 6 days after the trade.

This amendment replaces 0001209191-22-061328 (filed Dec 14, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Graham JuanCIK 0001879223Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 9, 2022Common StockSSaleDisposed−781$14.89−$11,629.0949,369Direct
Dec 12, 2022Common StockSSaleDisposed−1,407$14.50−$20,401.547,962Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)